Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

Data as of Jan 28
 -0.01 / -1.04%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-58.8M30.6M-114.4M-107.0M
Total Other Cash Flow5.2M10.4M10.9M5.4M
Funds From Operations-52.2M42.7M-101.0M-97.8M
Funds From/For Other Operating Expenses-403.0K16.2M4.7M-13.4M
Net Cash Flow - Operating Activities-51.8M26.5M-105.7M-84.4M
InvestingNet Cash Flow Investing-90.5M-144.1M135.2M12.1M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing142.8M115.4M3.1M47.0M
Exchange RateEffect of Exchange Rate on Cash-----26.0K26.0K
Net Change In Cash501.0K-2.3M32.7M-25.3M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.